Letters to the Editor

Second primary malignancy in multiple myeloma: does a prior malignancy matter?

Department of Oncology, McMaster University, Hamilton, ON
Department of Oncology, McMaster University, Hamilton, ON
Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY
Department of Oncology, McMaster University, Hamilton, ON
Institute for Clinical Evaluative Sciences, McMaster University, Hamilton, ON
Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
Department of Hematology and Oncology, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, Texas, USA Division of Hematology, Department of Internal Medicine, Mayo Clinic, Scottsdale, AZ
H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA
Department of Oncology, McMaster University, Hamilton, ON
Department of Oncology, McMaster University, Hamilton, ON
H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
Department of Oncology, McMaster University, Hamilton, ON
Haematologica Early view Feb 5, 2026 https://doi.org/10.3324/haematol.2025.300320